Anemia in Cancer Patients: Introduction and Overview

Abstract

Get full access to this article

View all access options for this article.

References

Glaspy

, Bukowski

, Steinberg

. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice: Procrit Study Group. J Clin Oncol. 1997; 15: 1218–1234.

Moliterno

A.R.

, Spivak

J.L.

. Anemia of cancer. Hematol Oncol Clin North Am. 1996; 10: 345–363.

Frenkel

E.P.

, Bick

R.L.

, Rutherford

C.J.

. Anemia of malignancy. Hematol Oncol Clin North Am. 1996; 10: 861–873.

Spivak

J.L.

. Cancer-related anemia: its causes and characteristics. Semin Oncol. 1994; 21(suppl 3): 3–8.

Henry

. Recombinant human erythropoietin for treatment of anemia in patients with advanced cancer. Semin Hematol. 1993; 30(suppl 6): 12–16.

Hyman

G.A.

. Studies of anemia of disseminated malignant neoplastic disease. 1. The hemolytic factor. Blood. 1954; 9: 911.